Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Documents (9899)

Showing 12 of 9899 View All
Showing 561 of 825 pages

Review of Gavi’s Performance-Based Funding component of its Health System Strengthening support

This review evaluates the design, implementation, and results of the Performance Based Funding (PBF) component of the Health System Strengthening (HSS) support of Gavi, the Vaccine Alliance (Gavi).

IC Mtg Minutes 11 September 2018

Inv -2018 -Mtg -03 1



G avi Alliance Investment Committee Meeting
11 September 2018
Teleconference


1. Chair?s report

1.1 Finding a quorum of members present, the meeting commenced at 14.07 Geneva
time on 11 September 2018 . Stephen Zinser , Investment Committee Chair,
chaired the meeting.

1.2 Standing declarations of interest were tabled to the Committee (Doc 01a ).

1.3 The minutes of the 15 Ma y 201 8 meeting were tabled to the Committee for
information (Doc 01b in the Committee pack). The minutes had been circulated
and approved by no -obje ction o n 4 July 2018 .

1.4 The Committee noted its Action sheet (Doc 01c) and the forward work plan
(Doc 01d).

------

2. Investment portfolio review

2.1 Jeanne Shen, Chief Investment Officer, update d the Committee on the
performance of the investment portfolio through July 2018 , as well as manager
activities and associated transactions since the previous Investment Committee
meeting (Doc 2) .

2.2 In the market review, Ms Shen noted continuing volatility in the second quarter .
She highlighted the strengthening of the US dollar , Federal Rese rve rate hikes and
the expectations for the European Central Bank to reduce security purchases , and
the impact these policies have had on financial market s.

2.3 It was noted that a modestly positive overall investment gain of US$ 5.2 million
thus far in 2018 was due to higher return s from interest on cash rather than the
returns from the long -term portfolio. She not ed that in terms of relative
performance whilst the YTD return on the Gavi portfolio is below the reference
index , recent changes are expected to yield relative improvement by the end of
2018 . It was noted that all longer term measures of performance relative to the
reference index continue to show solid results.

2.4 Referring to the long -term portfolio , Ms Shen stated that April -June performance
was negative whilst July performance was solid. She explained that equities
(particularly non -US assets) and multi -exposure were the main detractors over this
period .



Minutes

Subscribe to our newsletter